Decoy Therapeutics Inc. - DCOY
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | History | New | 31,676 | 28 | 0.0% | — | 1 | +31,676 | New | Q2 2025 | Aug 14, 2025 |
| UBS Group AG | History | Reduced | 18,138 | 16 | 0.0% | 0.0% | 2 | -15,674 | -46.36% | Q2 2025 | Aug 14, 2025 |
| GOLDMAN SACHS GROUP INC | History | New | 16,667 | 14 | 0.0% | — | 3 | +16,667 | New | Q2 2025 | Aug 14, 2025 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 15,560 | 13 | 0.0% | 0.0% | 4 | +4,057 | 35.27% | Q2 2025 | Aug 08, 2025 |
| BARCLAYS PLC | History | New | 8,024 | 7 | 0.0% | — | 5 | +8,024 | New | Q2 2025 | Feb 27, 2026 |
| CITIGROUP INC | History | New | 5,889 | 5 | 0.0% | — | 6 | +5,889 | New | Q2 2025 | Aug 11, 2025 |
| Tower Research Capital LLC (TRC) | History | Added to | 3,663 | 3 | 0.0% | 0.0% | 7 | +334 | 10.03% | Q2 2025 | Aug 15, 2025 |
| OSAIC HOLDINGS, INC. | History | Reduced | 59 | 0 | — | — | — | -103 | -63.58% | Q2 2025 | Sep 04, 2025 |
| ELEVATION POINT WEALTH PARTNERS, LLC | History | New | 61 | 0 | — | — | — | +61 | New | Q2 2025 | Feb 03, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 18 | 0 | — | — | — | +6 | 50.0% | Q2 2025 | Aug 14, 2025 |
| MORGAN STANLEY | History | No change | 7 | 0 | — | — | — | 0 | 0.0% | Q2 2025 | Aug 14, 2025 |
| SBI Securities Co., Ltd. | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q2 2025 | Aug 08, 2025 |
| BlackRock, Inc. | History | No change | 1 | 0 | — | — | — | 0 | 0.0% | Q2 2025 | Aug 12, 2025 |